This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ullmann, S. Articles by Pahl, A. Search for Related Content PubMed PubMed Citation Articles by Ullmann, S. Articles by Pahl, A. Social Bookmarking                         What's this?

RNA-Based Drug Screening Using Automated RNA Purification and Real-time RT-PCR1

QIAGEN, Hilden, Germany

Thorsten Hage

elbion AG, Radebeul, Germany

Regina Draheim

elbion AG, Radebeul, Germany

Ute Egerland

elbion AG, Radebeul, Germany

Uwe OelmÜller

QIAGEN, Hilden, Germany

Kay Brune

Institute of Pharmacology, University of Erlangen, Germany

Andreas Pahl

Institute of Pharmacology, University of Erlangen, Germany pahl{at}pharmakologie.uni-erlangen.de

A new system has been developed for RNA-based drug screening, and the feasibility of this approach has been demonstrated by the identification of new immunomodulating compounds. Peripheral blood mononuclear cells were chosen as the cellular assay system. Cells were either stimulated by TPA/ionomycin to produce T cell cytokines as asthma targets or stimulated by lipopolysaccharide to produce proinflammatory cytokines as targets for chronic obstructive pulmonary disease (COPD). The authors developed a new fully automated system for RNA purification from cells grown in 96-well plates. Gene expression was determined in 384-well plates using real-time quantitative one-tube RT-PCR. Small interdonor variation could be demonstrated. The assay system was validated with known immunosuppressants cyclosporine and dexamethasone. Screening of 800 compounds resulted in 9.5% compounds inhibiting the induction of at least 1 T cell derived cytokine and 6.8% compounds inhibiting at least 1 cytokine relevant for COPD. All these compounds were retested by analyzing remaining RNA from the 1st round of screening. The reproducibility of hits was between 56% and 74% for different cytokines. One compound selectively inhibited TNF, which was confirmed by IC₅₀ determination. Analyzing its effect on cells from different donors revealed little interdonor variation. In conclusion, the authors established fully automated RNA isolation and precise gene expression profiling using real-time RT-PCR for drug screening. (Journal of Biomolecular Screening 2004:95-102)

Key Words: mRNA quantification • real-time RT-PCR • automated RNA isolation • Asthma • COPD

Journal of Biomolecular Screening, Vol. 9, No. 2, 95-102 (2004)
DOI: 10.1177/1087057103262365


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Rosengren, H. Simko, L. Aryan, P. Axelsson-Lendin, J. Chmielewska, A. Mode, and V. Parrow Antisense and Sense RNA Probe Hybridization to Immobilized Crude Cellular Lysates: A Tool to Screen Growth Hormone Antagonists J Biomol Screen, April 1, 2005; 10(3): 260 - 269. [Abstract] [PDF]